why choose us

First received: June 28, 2023

Clinical Trial: Pembro Plus CAR T-cell Therapy in R/R in PMBCL

Study Status: Completed

Recruit Status: RECRUITING

Condition: Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Study Type: INTERVENTIONAL


Official Title: A Phase II Trial of Pembrolizumab in Combination With Chimeric Antigen Receptor Therapy in Patients With Relapsed/Refractory Primary Mediastinal B-cell Lymphoma

Brief Summary: This research study is evaluating the combination of drugs, pembrolizumab with chimeric antigen receptor (CAR) T-cell therapy, as a possible treatment for primary mediastinal B-cell lymphoma that has recurred after prior treatment.The names of the study drugs involved in this study are:- PembrolizumabStandard treatment will include:CAR T-cell therapy (either axicabtagene-ciloleucel or lisocabtagene maraleucel)CyclophosphamideFludarabine

Read more